Reaction ofGraft Against Host Dempster (1953) first suggested that a homograft containing immunologically competent cells might react against the recipient. If adult lymphoid cells are injected into unrelated animals to produce immunological tolerance, or to repopulate the marrow of irradiated animals, in either case the recipients are unable to react against the injected cells and the stage is set for a graftversus-host reaction. This is probably the explanation of 'runt' disease in tolerant mice (Billingham & Brent 1959 ) and 'homologous' or 'secondary' disease in irradiated animals (Trentin 1956 ). Mice with runt disease fail to thrive and are susceptible to infection. A similar disease can affect tolerant chickens; such animals often develop gross splenomegaly (Simonsen 1957) . A proportion of irradiated and marrow grafted animals suffer from diarrhoea and wasting (Graber et al. 1958 ). There may be, in addition, a hemolytic process (Porter 1960 , Piomelli & Brooke 1960 .
The observation that foetal Iymphoid tissue, which can presumably become tolerant to host antigens, does not produce these syndromes is evidence in favour of the above interpretation of these diseases (Barnes et al. 1958 , Uphoff 1958 , Porter 1959 .
Any attempts to utilize immunological tolerance or irradiation and marrow grafting for clinical purposes would raise the theoretical possibility of a graft-versus-host reaction, unless only immunologically incompetent or foetal cells were used as grafts.
The principles I have outlined are probably applicable to most tissue grafts. Notable exceptions are cornea, the anterior chamber of the eye and cartilage, where the effector mechanism lacks access; grafts in the brain, from where it seems antigen cannot reach the reacting centre, and non-living structural grafts, e.g. arteries. The ovary and, to a lesser extent, other endocrine glands seem to be less antigenic than most other tissues, and may survive for long periods in homologous hosts. In the kidney typical rejection occurs.
Until more is known of the discrete chemistry of transplantation antigens, of the biochemical changes occurring in sensitized lymphoid cells and of the mechanism of graft destruction, attempts to prevent rejection must remain empirical.
Dr N A Mitchison (National Institute for Medical Research, Mill Hill, London) Immunological Paralysis in the Adult Antigens have now been tested for toleranceinducing capacity in sufficient number for some generalizations to emerge. A few antigens appear to immunize so strongly that attempts to use them to induce tolerance have so far failed. To this category of obligatory immunogens belong some bacterial antigens such as endotoxin and flagellin, and possibly also bacteriophages. On the other hand, at least one example is known of a zero immunogen, a term that describes substances which fail altogether to immunize unless administered with adjuvants such as alum or Freund's adjuvant. Bovine y-globulin (BGG) was discovered by Dresser (1961) to belong to this category, and he was able to show that a single injection of microgram quantities of BGG induced immunological tolerance in adult mice. Tolerance in this sense implies that treated animals are subsequently unable, for some time, to become immunized by the antigen administered together with adjuvant. In between these two categories lies a range of antigens which differ in their immunogenic capacity. None of them induces tolerance in adult animals when g38 Proceedings ofthe Royal Society ofMedicine administered in a single dose, except for pneumococcal polysaccharide; this constitutes an exception probably because it is degraded only very slowly in the body and so cannot be administered except in the form of a prolonged immunological stimulus.
All the intermediate antigens can induce tolerance in adult animals which have been irradiated or treated with radiomimetic drugs, and also in the newborn.
Within the intermediate range a division can be drawn between the weak immunogens and the strong ones. In the case of the weak immunogens, such as pneumococcal polysaccharide, bovine serum albumin (BSA) in the mouse, and weak histocompatibility factors (Brent & Gowland 1962) , tolerance can be induced in adult animals by cumulative treatment involving the administration of the antigen over a long period. For the stronger immunogens, such as strong histocompatibility factors controlled in the mouse by the H-2 locus, heterologous cells and enterobacterial 0-carbohydrate, cumulative treatment of normal adults does not induce tolerance. For these antigens irradiation or drug treatment is needed, or a course of treatment which begins in the newborn.
Tolerance in the sense employed here has sometimes been termed 'immunological paralysis'. The terminology has been confused in the past by attempts to draw a distinction between the two phenomena. At one time, for example, it was believed that immunological paralysis operated without a central failure of response. It was supposed that antibody was produced on a treadmill and was promptly absorbed by depots of antigen. Now that this hypothetical mechanism has been excluded there is no reason to draw a distinction between the two phenomena. The terms 'tolerance' and 'paralysis' can therefore be used interchangeably. In either case what is meant is a specific failure of response on the part of the immunologically reactive cell. In practice, the criteria for recognizing the condition are: (1) The condition can be broken or abolished by transfer of reactive cells from a normal animal, thus reequipping the body with cells of the appropriate reactivity.
(2) The condition must be reasonably stable and long lasting, i.e. loss of tolerance should not follow immediately after the disappearance of free antigen from the body but rather be delayed until a process of cellular change has run its course.
Upon looking through this classification of antigens it is immediately clear that an inverse relationship exists between immunizing capacity and tolerance-inducing capacity. The stronger the immunogen the more difficult it becomes for it to induce tolerance. Equally, circumstances which reduce the capacity to give an immune response, such as treatment with radiation or immunological maturity, tend to facilitate the induction of tolerance.
What is the mechanism which underlies this relationship? The most attractive hypothesis runs as follows: All antigens elicit from the immunologically responsive tissue a double response inducing on the one hand tolerance and on the other hand immunity. For strong immunogens all that is normally detected is the immunity, and the tolerance which is induced side by side remains undetected. The weaker the immunogen the easier it becomes to detect the simultaneous induction of tolerance. It seems likely that heterogeneity among immunologically reactive cells underlies this dual response. Interaction with antigens-renders some cells tolerant and sets others on a course leading to antibody synthesis.
An Example ofParalysis Treatment of mice with BSA has attracted my attention (Mitchison 1962) as a system for examining the-induction of tolerance because the antigen behaves in these animals as a weak immunogen. Thus the balance between tolerance and immunization is delicate.
Antibody to albumin can be conveniently assayed by the technique of Farr, i.e. the precipitation of complexes of antibody with radioactive antigen by addition of ammonium sulphate. Following immunization with Freund's adjuvant, combining capacities of the order of 100 ,±g of BSA per ml of serum can usually be detected. The administration of a single dose of BSA by itself reduces the capacity of a mouse to respond later to the antigen in adjuvant, but tolerance induced in this way is never complete. However, if mice are given a course of injections of BSA over a more prolonged period, e.g. 5 mg three times a week for three months, their reaction to the antigen in adjuvant can be suppressed completely.
The kinetics of cumulative BSA tolerance follow the pattern predicted by the hypothesis of heterogeneity. During the course of treatment the mice make some antibody as a result of the tolerance-inducing injections alone, before the injection of adjuvant. The amount of this type of antibody varies with the dose rate. The largest amounts have been found at a dose rate of approximately 1 mg three times a week, and with this regimen the maximum is not reached for ten weeks. At higher dose rates a lower peak is reached after a shorter interval. Doses below 1 mg three times a week have not yet been investigated in full, but it appears that the antibody level rises more slowly, as though fewer cells become stimulated.
Section of Medicine
'As regards the effect of the regimens on the subsequent response to antigen in adjuvant, the rule is that the response falls off logarithmically during the regimen. The fastest fall-off occurs with high dose rates. Defining the half-paralysis time as the length of regimen needed for the response to antigen in adjuvant to drop to one half, a regimen of 5 mg three times a week has a half-paralysis time of between two and three weeks. By the use of the Farr method it is therefore possible to follow the logarithmic decline under this regimen for at least three months. The time involved appears to rule out accumulation of antigen in some intracellular depot to account for the induction of tolerance. We must therefore be dealing with a process of cell turnover. It might be argued that the logarithmic decline in response represents simply the dying-off of a fraction of the population of reactive cells which is initially stimulated to produce antibody. As they die off they reveal an underlying population of tolerant cells.'
However, this hypothesis does not offer a satisfactory account of the details of the kinetics. On the present evidence the best hypothesis is one of progressive recruitment of tolerant cells, the rate of recruitment being highest at high dose rates. This in turn implies that at any one moment only a fraction of the cellular population is susceptible to the induction of tolerance by albumin. The higher the concentration of albumin in the body the larger the fraction; or perhaps the fraction is constant in size, but the probability of a cell becoming tolerant depends on the concentration of antigen to which it is exposed. Dresser's findings with BGG fit well into this framework. The tolerance-susceptible fraction for this'antigen can be assumed to comprise the entire cellular population of the normal animal; treatment with adjuvants, whether incorporated with the BGG or administered by a separate route, brings a portion of the cellular population out of the tolerancesusceptible phase.
Cellular Heterogeneity
Two types of cellular heterogeneity can be imagined. The first theorydirectional heterogeneityassumes that immunologically reactive cells mature from stem cells (Medawar 1959) . At the end of maturation, contact of the cell with antigen results in antibody synthesis, but during an intermediate stage of maturation contact with antigen results in the cell becoming tolerant. An essential feature of this theory is that tolerancesusceptible cells turn into cells potentially capable of making antibody, but that the reverse transition does not occur. The second theorycyclical heterogeneityalso assumes that upon contact with antigen some cells of the lymphon become tolerant while others produce antibody, but it assumes that transitions in both directions occur.' Possibly the two phases correspond to different stages in the mitotic cycle, or possibly to different anatomical positions in the body.
Directional heterogeneity has the special merit' of accounting for the susceptibility to paralysis of the newborn animal, since it can be assumed that at this stage comparatively few immunologically reactive cells have completed their maturation. However, the balance of the evidence now seems to weigh against this theory. Howard & Michie (1962) have shown that the newborn mouse is able to react immunologically against histocompatibility antigens. Under treatment with BSA the newborn mouse appears to react qualitatively in much the same way as the adult, but does so more rapidly. Thus, a tolerance-i-ducing regimen which in the adult elicits some immunity but results eventually in tolerance elicits the same responses in the newborn, but the half-paralysis time is much reduced.
Radiation, treatment with 6-mercaptopurine and hydrocortisone have also been found to speed up the induction of tolerance without completely suppressing the transient immune response. These agents appear to facilitate the induction of tolerance in two ways: (1) By reducing the immune response and (2) by speeding the recruitment of tolerant cells in a given tolerance-inducing regimen. Following 600r, for example, a regimen of as little as 40 Vg BSA three times a week induces complete tolerance within ten weeks. The concentration of antigen in the body is so low in this experiment that contact with only a few molecules of antigen must be capable of paralysing cells. Overdose, at least at the cellular level, cannot therefor'e te an essential condition for paralysis.
An interesting prediction can be made from the hypothesis of cyclical heterogeneity. It ought to be possible to synchronize the transitions of cellular populations between the tolerance-and immunitysusceptible phases. Preliminary experiments with this aim in view have been undertaken with a list of agents which includes small doses of radiation, hydrocortisone, 6-mercaptopurine, adenine, and thymidine. In every case the rate of entry into paralysis has been altered. A promising feature of these experiments is the way in which variation of the interval between treatment with agent and injection of the antigen alters the effect.
Optimal Treatment for Paralysis Certain practical conclusions can be drawn from this investigation: (1) Where tolerance is desired the weaker the immunogen the better. It remains to be seen whether antigens of clinical interest can be brought to the condition of BGG and prepared in a zero immuniogen form. The 32 possibility of using haptens requires exploration.
(2) The antigen should be administered in a form where it disseminates throughout the body. The more soluble the antigen the better. Fortunately this aim usually coincides in practice with the preceding one. (3) Both prolonged duration and a high dose rate are desirable. In theory there seems to be no reason why very low dose rates should not be effective in inducing tolerance provided that they can be maintained for long enough. (4) Treatment with agents which reduce the immune response and speed up cell turnover is desirable.
(5) A search should be made for agents which bring cells into the tolerance-susceptible phase. Dresser D W (1961) Developments in transplantation liology have important implications in relation to the surgery of replacement, the treatment of auto-immune disease, the natural history of tumours, and the possibility of treating cancer by immunological methods. In addition they are beginning to shed light on some of the unexplained disorders of mother and feetus which arise during pregnancy, and are in consequence of interest to the obstetrician as well as to the physician and surgeon.
The Surgery ofReplacement In the surgery of replacement extensive use is made of autografts, but. until recently the use of homografts has been restricted to (1) homografts of cornea and cartilage, which may survive indefinitely provided that they remain avascular;
(2) homografts of bone, soft connective tissues and blood vessel segments, which do not survive permanently but are nevertheless useful because they may be systematically replaced by rcgenerating host tissue; and (3) homografts of skin which are useful as a temporary cover in severely burned patients. During the last few years, however, there have been numerous reports concerning the clinical use of homotransplants of whole kidneys and also of bone marrow, and the possibility of transplanting other organs is being studied experimentally in many centres.
Organ transplantation: It has now been proved beyond doubt that transplantation of a whole kidney from an identical twin donor to a patient with irreversible renal failure can be a life-saving procedure. The first successful operation of this kind was reported by Merrill et al. (1956) , and since then there have been at least 24 more, all except one of which appear to have been technically successful. In two cases the original disease has recurred in the transplant; the remaining recipients, and all the donors about whom the writer has been able to obtain information, are well and have good renal function. In Edinburgh we have performed two such operations, and the donors and recipients are alive and well, in the first case two and a half years, and in the second six months, after transplantation.
When a kidney is transplanted from a donor other than an identical twin it is customary at the present time to try to reduce the recipient's capacity to reject the transplant by such procedures as whole body irradiation; administration of antimetabolites, alkylating agents or steroids; and local irradiation of the spleen, the thymus, the site of transplantation or the transplant itself. There have been many failures, more perhaps from complications of the treatment than from rejection of the transplant, but there have been a few quite remarkable results. Thus, for example, among the cases known to the writer there are two who are living more than three years after receiving a transplant from a non-identical twin (Hamburger et al. 1962 , Murray et al. 1962 , three who are alive more than a year after receiving a transplant from a relative other than a twin (Hamburger et al. 1962; Hamburger, personal communication) , and one who is alive more than a year after receiving a transplant from an unrelated cadaver (Murray et al. 1962; Murray, personal communication) . In addition there are two patients who died seventeen months after transplantation, one from slow rejection of the transplant, the other from septicamia (Kiiss et a. 1962; Legrain, personal communication). Of the 7 Edinburgh cases who received a transplant from a parent or sibling, 4 are alive after periods ranging from three to ten months and the longest survivor shows completely normal renal function with a creatinine clearance of 90 ml/min (Woodruff 1963a; Woodruff, Robson, Nolan, Lambie, Wilson & Clarke 1963, in press).
It seems likely that even with currently available forms of treatment the results could be improved
